Product Information
KETAMINE 500 MG/10 ML VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $0.5397 per ML under NDC 65219018810. Its NADAC has been published 28 times since Dec 17, 2025.
Strength
50 mg/mL
Manufacturer
Fresenius Kabi USA, LLCNDC
65219018810
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR; INTRAVENOUS
Last Updated
6/17/2026
Active Ingredients
KETAMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215808On Market Since
7/10/2023
Pharmacological Classes
Price Statistics
The NADAC for KETAMINE 500 MG/10 ML VIAL has been published 28 times since Dec 17, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5397 per ML |
|---|---|
| All-time high | $0.5397 (Jun 24, 2026) |
| All-time low | $0.5213 (Mar 18, 2026) |
| 52-week high | $0.5397 |
| 52-week low | $0.5213 |
| Median price | $0.5315 |
| Average price | $0.5283 |
| Largest weekly change | +3.0% (Jun 17, 2026) |
| Weeks tracked | 28 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the ketamine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of KETAMINE 500 MG/10 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for KETAMINE 500 MG/10 ML VIAL, manufactured by Fresenius Kabi USA, LLC, is $0.5397 per ML (NDC 65219018810), effective Jun 24, 2026.
How has the price of KETAMINE 500 MG/10 ML VIAL changed over time?
Over the history we have for it, the NADAC for KETAMINE 500 MG/10 ML VIAL has held within roughly two percent of its current level. It has been tracked across 28 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for KETAMINE 500 MG/10 ML VIAL?
Since Dec 17, 2025, the NADAC for KETAMINE 500 MG/10 ML VIAL has ranged from a low of $0.5213 (Mar 18, 2026) to a high of $0.5397 (Jun 24, 2026), with a median of $0.5315 per ML.
Are there cheaper alternatives to KETAMINE 500 MG/10 ML VIAL?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of KETAMINE 500 MG/10 ML VIAL, so no direct lower-cost alternative is listed.
Who manufactures KETAMINE 500 MG/10 ML VIAL?
KETAMINE 500 MG/10 ML VIAL (NDC 65219018810) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification